Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

NCT05018416 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Diseases
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

BIOLOGICAL: Renal Autologous Cell Therapy (REACT)

Sponsor

Prokidney